Advances in Therapy | ScienceGate

Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies

Advances in Therapy ◽

10.1007/s12325-021-02024-x ◽

2022 ◽

Author(s):

Francesca Civoli ◽

Barbara Finck ◽

Helen Tang ◽

Jennifer Hodge ◽

Hillary O’Kelly ◽

...

Keyword(s):

Clinical Studies ◽

Healthy Subjects

Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

Advances in Therapy ◽

10.1007/s12325-021-02022-z ◽

2022 ◽

Author(s):

H. Tilman Steinmetz ◽

Moushmi Singh ◽

Joseph Milce ◽

Mohamad Haidar ◽

Achim Rieth ◽

...

Keyword(s):

Multiple Myeloma ◽

Clinical Practice ◽

Routine Clinical Practice ◽

Combination Therapies ◽

Refractory Multiple Myeloma

Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France

Advances in Therapy ◽

10.1007/s12325-021-01956-8 ◽

2022 ◽

Author(s):

Montserrat Roset ◽

Mayur Amonkar ◽

Renna Patel ◽

Núria Lara ◽

Smita Kothari

Keyword(s):

Colorectal Cancer ◽

Clinical Outcomes ◽

Real World ◽

Chart Review ◽

Retrospective Chart Review ◽

Standard Of Care ◽

Treatment Patterns ◽

Review Study

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

Advances in Therapy ◽

10.1007/s12325-021-02007-y ◽

2022 ◽

Author(s):

Mário Fontes-Sousa ◽

Helena Magalhães ◽

Alicia Oliveira ◽

Filipa Carneiro ◽

Filipa Palma dos Reis ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Treatment Options ◽

Advanced Renal Cell Carcinoma

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach

Advances in Therapy ◽

10.1007/s12325-021-02032-x ◽

2022 ◽

Author(s):

Marjanne A. Piena ◽

Sonja Kroep ◽

Claire Simons ◽

Elisabeth Fenwick ◽

Gerard T. Harty ◽

...

Keyword(s):

Multiple Sclerosis ◽

Decision Making ◽

Optimal Treatment ◽

Innovative Approach ◽

Treatment Sequence ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs

Advances in Therapy ◽

10.1007/s12325-021-01997-z ◽

2022 ◽

Author(s):

Charmi Patel ◽

Ahong Huang ◽

Li Wang ◽

Yoshita Paliwal ◽

Kruti Joshi

Keyword(s):

Resource Utilization ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Treatment Patterns ◽

Patient Journey

Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study

Advances in Therapy ◽

10.1007/s12325-021-01968-4 ◽

2022 ◽

Author(s):

Shu Hashimoto ◽

Ryoko Sorimachi ◽

Tatsunori Jinnai ◽

Masakazu Ichinose

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cohort Study ◽

Pulmonary Disease ◽

Diagnostic Criteria ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence

Advances in Therapy ◽

10.1007/s12325-021-01924-2 ◽

2022 ◽

Author(s):

Yongmei Wang ◽

Fanbo Jing ◽

Haibo Wang

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Narrative Review ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

Advances in Therapy ◽

10.1007/s12325-021-01990-6 ◽

2022 ◽

Author(s):

Stefan Schreiber ◽

Shomron Ben-Horin ◽

Rieke Alten ◽

René Westhovens ◽

Laurent Peyrin-Biroulet ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Rheumatic Diseases ◽

Bowel Disease ◽

Inflammatory Bowel

White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

Advances in Therapy ◽

10.1007/s12325-021-01996-0 ◽

2022 ◽

Author(s):

Christian Jackisch ◽

Federico Manevy ◽

Suzanne Frank ◽

Nicki Roberts ◽

Jason Shafrin

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Subcutaneous Injection ◽

Healthcare Providers ◽

White Paper ◽

Fixed Dose ◽

Value Of Time ◽

Breast Cancer Therapy ◽

Dose Combination ◽

Time Savings

Advances in Therapy
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer-Verlag

Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies

Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach

Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs

Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

Export Citation Format

Advances in TherapyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer-Verlag

Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies

Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach

Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs

Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

Advances in Therapy
Latest Publications